Given the protective ability of Akt2 in diabetes and the above mentioned studies, we tried to hypothesize that Akt2 can inhibit the expression of cGAS–STING pathway in diabetes progression and thus inhibit the inflammatory response induced by diabetes. The gene discussed is STING1; the disease is diabetes mellitus.